8-KFiled Aug 12, 8:00 PM ET

Aveanna Healthcare Reports Q3 2026 Results (Press Release)

$AVAH · Aveanna Healthcare Holdings, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Aveanna Healthcare Reports Q3 2026 Results (Press Release)

What Happened

  • Aveanna Healthcare Holdings, Inc. (AVAH) filed a Form 8-K on August 13, 2026 to report its financial results for the three- and six-month periods ended July 4, 2026. The company issued a press release announcing those results, which is furnished as Exhibit 99.1 to the 8-K.
  • The filing also includes Regulation FD disclosure (Item 7.01) regarding the information in the press release. The Form 8-K was signed by Deborah Stewart, Chief Accounting Officer, on August 13, 2026.

Key Details

  • Press release dated August 13, 2026 announcing quarterly results for the three and six months ended July 4, 2026 (Exhibit 99.1).
  • Reported under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure) of Form 8-K.
  • The press release is incorporated by reference in the 8-K; detailed financial figures are in Exhibit 99.1 (see the full filing or company release for numbers).
  • No management changes or other material events (e.g., mergers, bankruptcies) were disclosed in this Form 8-K.

Why It Matters

  • This filing signals that Aveanna has publicly released its latest quarterly earnings information; investors should review the press release and accompanying financial statements for revenue, earnings, margins, cash flow and any commentary on outlook or guidance.
  • The Regulation FD disclosure indicates the company has made the information public to all investors simultaneously, which can affect market reaction once numbers are reviewed.
  • For specifics and to evaluate impact on valuation or investment decisions, retail investors should read Exhibit 99.1 (the press release) and any subsequent SEC filings (e.g., 10-Q) that provide full financial statements and management discussion.